Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons

Neuroscience

Volumn 144, Issue 1, 2007, Pages 119-127

  Park, S Y ^a   Tournell, C ^a   Sinjoanu, R C ^a   Ferreira, A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

apoptosis; beta amyloid; calpain; caspase 3; neurotoxicity; tau

Indexed keywords

AMYLOID BETA PROTEIN; CALPAIN; CASPASE 3; ESTROGEN; SEX HORMONE; TAU PROTEIN; TESTOSTERONE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; EMBRYO; HIPPOCAMPUS; MOLECULAR WEIGHT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CALPAIN; CASPASE 3; CELLS, CULTURED; DIHYDROTESTOSTERONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ESTROGENS; FEMALE; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NERVE DEGENERATION; NEURITES; NEURONS; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; TAU PROTEINS; TESTOSTERONE;

EID: 33751557958     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.09.012     Document Type: Article

References (68)

1. Alvarez A., Toro R., Caceres A., and Maccioni R.B. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett 459 (1999) 421-426
2. Amadoro G., Ciotti M.T., Costanzi M., Cestari V., Calissano P., and Canu N. NMDA receptor mediates tau-induced neurotoxicity by calapin and ERK/MAPK activation. Proc Natl Acad Sci U S A 103 (2006) 2892-2897
3. Baldereschi M., Di Carlo A., Lepore V., Bracco L., Maggi S., Grigoletto F., Scarlato G., and Amaducci L. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50 (1998) 996-1002
4. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
5. Bottenstein J., Hayashi I., Hutchings S., Masui H., Mather J., McClure D.B., Ohasa S., Rizzino A., Sato G., Serrero G., Wolfe R., and Wu R. The growth of cells in serum-free hormone-supplemented media. Methods Enzymol 58 (1979) 94-109
6. Brinton R.D. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem 8 (2001) 121-133
7. Celsi F., Ferri A., Casciati A., D'Ambrosi N., Rotilio G., Costa A., Volonte C., and Carri M.T. Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem Int 44 (2004) 25-33
8. Cherrier M.M., Matsumoto A.M., Amory J.K., Asthana S., Bremner W., Peskind E.R., Raskind M.A., and Craft S. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64 (2005) 2063-2068
9. Chung C.W., Song Y.H., Yoon W.J., et al. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis 8 (2001) 162-172
10. Czogalla A., and Sikorski A.F. Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62 (2005) 1913-1924
11. Ekinci F.J., Malik K.U., and Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. J Biol Chem 274 (1999) 30322-30327
12. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 52 (2000) 513-556
13. Fasulo L., Ugolini G., Visintin M., Bradbury A., Brancolini C., Versillo V., Novak M., and Cattaneo A. The neuronal microtubule-associated tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem 75 (2000) 624-633
14. Ferreira A., Busciglio J., and Caceres A. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau. Brain Res Dev Brain Res 49 (1989) 215-228
15. Ferreira A., Lu Q., Orecchio L., and Kosik K.S. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci 9 (1997) 220-234
16. Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., Lu M., Fu Y., Garcia-Sierra F., LaPointe N., Miller R., Berry R.W., Binder L.I., and Cryns V.L. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100 (2003) 10032-10037
17. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120 (1984) 885-890
18. Goodenough S., Schafer M., and Behl C. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol 84 (2003) 301-305
19. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66 (1996) 1836-1844
20. Goslin K., and Banker G.A. Rat hippocampal neurons in low-density culture. In: Banker G., and Goslin K. (Eds). Culturing nerve cells (1991), MIT, Cambridge, MA 251-283
21. Gouras G.K., Xu H., Gross R.S., Greenfield J.P., Hai B., Wang R., and Greengard P. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A 97 (2000) 1202-1205
22. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18 (2000) 347-358
23. Green P.S., Bishop J., and Simpkins J.W. 17 alpha-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17 (1997) 511-515
24. Gridley K.E., Green P.S., and Simpkins J.W. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778 (1997) 158-165
25. Gridley K.E., Green P.S., and Simpkins J.W. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol 54 (1998) 874-880
26. Grynspan F., Griffin W.R., Cataldo A., Katayama S., and Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res 763 (1997) 145-158
27. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem 77 (2001) 1319-1326
28. Hogervorst E., Williams J., Budge M., Barnetson L., Combrinck M., and Smith A.D. Serum total testosterone is lower in men with Alzheimer's disease. Neurol Endocrinol Lett 22 (2001) 163-168
29. Honda K., Shimohama S., Sawada H., Kihara T., Nakamizo T., Shibasaki H., and Akaike A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res 64 (2001) 466-475
30. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., and Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci 22 (2002) 2115-2124
31. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., and Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48 (1997) 1517-1521
32. Keller J.N., Germeyer A., Begley J.G., and Mattson M.P. 17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron. J Neurosci Res 50 (1997) 522-530
33. Kelly B., Vassar R., and Ferreira A. Beta-amyloid-induced dynamin I depletion in hippocampal neurons: A potential mechanisms for early cognitive decline in Alzheimer's disease. J Biol Chem 280 (2005) 31746-31753
34. Kim H., Bang O.Y., Jung M.W., Ha S.D., Hong H.S., Huh K., Kim S.U., and Mook-Jung I. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett 302 (2001) 58-62
35. Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., and Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1 (1988) 827-834
36. Kosik K.S., Joachim C.L., and Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83 (1986) 4044-4048
37. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
38. Li X., Schwartz P.E., and Rissman E.F. Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology 66 (1997) 63-67
39. Moffat S.D., Zonderman A.B., Metter E.J., Kawas C., Blackman M.R., Harman S.M., and Resnick S.M. Free testosterone and risk for Alzheimer disease in older men. Neurology 62 (2004) 188-193
40. Morley J.E. Androgens and aging. Maturitas 38 (2001) 61-71 discussion 71-63
41. Negishi T., Ishii Y., Kyuwa S., Kuroda Y., and Yoshikawa Y. Inhibition of staurosporine-induced neuronal cell death by bisphenol A and nonylphenol in primary cultured rat hippocampal and cortical neurons. Neurosci Lett 353 (2003) 99-102
42. Paganini-Hill A., and Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156 (1996) 2213-2217
43. Parihar M.S., and Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 11 (2004) 456-467
44. Park S.Y., and Ferreira A. The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25 (2005) 5365-5375
45. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72 (1999) 1552-1563
46. Pike C.J. Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons. Brain Res 919 (2001) 160-165
47. Polo-Kantola P., and Erkkola R. Alzheimer's disease and estrogen replacement therapy: where are we now?. Acta Obstet Gynecol Scand 80 (2001) 679-682
48. Rapoport M., and Ferreira A. PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. J Neurochem 74 (2000) 125-133
49. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., and Ferreira A. Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99 (2002) 6364-6369
50. Rissman R.A., Poon W.W., Blurton-Jones M., Oddo S., Torp R., Vitek M.P., LaFerla F.M., Rohn T.T., and Cotman C.W. Caspase-cleavage of tau is an early event in Alzheimer's disease tangle pathology. J Clin Invest 114 (2004) 121-130
51. Rosario E.R., Chang L., Stanczyk F.Z., and Pike C.J. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292 (2004) 1431-1432
52. Saito K., Elce J.S., Hamos J.E., and Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90 (1993) 2628-2632
53. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10 (1994) 373-403
54. Shah R.D., Anderson K.L., Rapoport M., and Ferreira A. Estrogen-induced changes in the microtubular system correlate with a decreased susceptibility of aging neurons to beta amyloid neurotoxicity. Mol Cell Neurosci 24 (2003) 503-516
55. Siman R., Baudry M., and Lynch G. Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci U S A 81 (1984) 3572-3576
56. Stern E.A., Bacskai B.J., Hickey G.A., Attenello F.J., Lombardo J.A., and Hyman B.T. Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J Neurosci 24 (2004) 4535-4540
57. Sur P., Sribnick E.A., Wingrave J.M., Nowak M.W., Ray S.K., and Banik N.L. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 971 (2003) 178-188
58. Takashima A., Noguchi K., Sato K., Hoshino T., and Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A 90 (1993) 7789-7793
59. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
60. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
61. Tsuji T., Shimohama S., Kimura J., and Shimizu K. m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci Lett 248 (1998) 109-112
62. Ugolini G., Cattaneo A., and Novak M. Co-localization of truncated tau and DNA fragmentation in Alzheimer's disease neurones. Neuroreport 8 (1997) 3709-3712
63. Veeranna, Kaji T., Boland B., Odrljin T., Mohan P., Basavarajappa B.S., Peterhoff C., Cataldo A., Rudnicki A., Amin N., Li B.S., Pant H.C., Hungund B.L., Arancio O., and Nixon R.A. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol 165 (2004) 795-805
64. Weaver Jr. C.E., Park-Chung M., Gibbs T.T., and Farb D.H. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761 (1997) 338-341
65. Wood J.G., Mirra S.S., Pollock N.J., and Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci U S A 83 (1986) 4040-4043
66. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., and Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4 (1998) 447-451
67. Yankner B.A., and Mesulam M.M. Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med 325 (1991) 1849-1857
68. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Maric D., Barker J.L., and Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12 (2001) 1919-1923